Quarterly report pursuant to Section 13 or 15(d)

Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statements of Cash Flows (Detail)

v2.4.0.8
Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statements of Cash Flows (Detail) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Condensed Financial Statements [Line Items]        
Revenues $ 254,234 $ 225,954 $ 483,459 $ 393,090
Operating expenses 174,569 143,401 340,594 260,147
Gain (Loss) on Derivative Instruments, Net, Pretax 0 17 0 54
Other 1,032 (459) 1,927 (661)
Cash flows from operating activities:        
Net income 15,837 8,374 3,445 8,946
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization 36,180 32,280 70,517 61,792
Gain on disposition of assets 479 0 30,152 0
(Gain) loss on disposition of assets (1,019) (517) (890) (1,665)
Deferred income tax benefit     (8,358) 1,800
Other Asset Impairment Charges       0
Expenses not requiring cash     8,748 7,989
Equity in net earnings of subsidiaries 0 0 0 0
Change in other assets     (777) 6,711
Change in accounts receivable     (1,066) (32,285)
Change in accrued income taxes     (3,987) 2,179
Change in liabilities     5,789 (9,543)
Net cash provided by operating activities     103,573 45,924
Cash flows from investing activities:        
Capital expenditures (12,250)   (106,188) (63,537)
Cash Acquired from Acquisition     0 (117,991)
Proceeds from the sale of assets     3,346 2,901
Net Cash Provided by (Used in) Investing Activities     (102,842) (178,627)
Cash flows from financing activities:        
Proceeds from debt issuance     400,000 125,000
Repayments of long term debt     (425,000) 0
Paydown on term note     (5,000) (5,000)
Payment of debt issuance costs     (7,425) (5,386)
Payments of debt extinguishment costs     (26,214) 0
Excess tax benefit from stock-based compensation     665 (189)
Intercompany advances, net     0 0
Net cash used in financing activities     (62,974) 114,425
Net change in cash and cash equivalents     (62,243) (18,278)
Cash and cash equivalents, beginning of year     148,689 87,886
Cash and cash equivalents, end of period 86,446 69,608 86,446 69,608
Total operating gross margin 43,485 50,273 72,348 71,151
General and Administrative Expense 7,007 22,203 15,971 35,049
Total operating income 37,497 28,587 57,267 37,767
Interest Expense 10,599 10,741 22,638 20,747
Interest income 88 2,203 120 2,262
Total other expense (9,958) (8,980) (50,743) (19,092)
Income (benefit) before income taxes 27,539 19,607 6,524 18,675
Income tax expense 11,702 11,233 3,079 9,729
Less: Net income (loss) attributable to noncontrolling interest 156 93 313 73
Net income attributable to controlling interest 15,681 8,281 3,132 8,873
Parent [Member]
        
Condensed Financial Statements [Line Items]        
Revenues 0 0 0 0
Operating expenses 0 0 0 0
Gain (Loss) on Derivative Instruments, Net, Pretax   17   54
Other 0 0 0 0
Cash flows from operating activities:        
Net income 15,681 8,281 3,132 8,873
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization 0 0 0 0
Gain on disposition of assets 479 0 30,152 0
(Gain) loss on disposition of assets 0 0 80 0
Deferred income tax benefit     (19,621) (4,560)
Other Asset Impairment Charges       0
Expenses not requiring cash     7,939 5,218
Equity in net earnings of subsidiaries (20,659) (13,828) (31,149) (14,007)
Change in other assets     37,589 45,072
Change in accounts receivable     0 (125,337)
Change in accrued income taxes     (5,231) (35,297)
Change in liabilities     (19,629) 1,780
Net cash provided by operating activities     3,262 (118,258)
Cash flows from investing activities:        
Capital expenditures     0 0
Cash Acquired from Acquisition       0
Proceeds from the sale of assets     0 0
Net Cash Provided by (Used in) Investing Activities     0 0
Cash flows from financing activities:        
Proceeds from debt issuance     400,000 125,000
Repayments of long term debt     (425,000)  
Paydown on term note     (5,000) (5,000)
Payment of debt issuance costs     (7,425) (5,386)
Payments of debt extinguishment costs     (26,214)  
Excess tax benefit from stock-based compensation     665 (189)
Intercompany advances, net     (2,619) (23,712)
Net cash used in financing activities     (65,593) 90,713
Net change in cash and cash equivalents     (62,331) (27,545)
Cash and cash equivalents, beginning of year     88,697 42,251
Cash and cash equivalents, end of period 26,366 14,706 26,366 14,706
Total operating gross margin 0 0 0 0
General and Administrative Expense 234 46 304 90
Total operating income (234) (46) (384) (90)
Interest Expense 11,299 11,719 24,014 22,699
Interest income 96 1,437 535 3,006
Total other expense 8,977 3,563 (22,482) (5,632)
Income (benefit) before income taxes 8,743 3,517 (22,866) (5,722)
Income tax expense (6,938) (4,764) (25,998) (14,595)
Less: Net income (loss) attributable to noncontrolling interest 0 0 0 0
Net income attributable to controlling interest 15,681 8,281 3,132 8,873
Guarantor [Member]
        
Condensed Financial Statements [Line Items]        
Revenues 143,171 121,801 266,602 226,144
Operating expenses 80,929 63,830 157,477 122,408
Gain (Loss) on Derivative Instruments, Net, Pretax   0   0
Other 57 (352)   (250)
Cash flows from operating activities:        
Net income 22,148 6,809 34,191 16,794
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization 21,008 18,548 41,175 37,380
Gain on disposition of assets 0 0 0 0
(Gain) loss on disposition of assets (512) (843) (432) (1,952)
Deferred income tax benefit     8,917 6,261
Other Asset Impairment Charges       0
Expenses not requiring cash     (997) 1,563
Equity in net earnings of subsidiaries 0 0 0 0
Change in other assets     (51,431) (42,264)
Change in accounts receivable     (6,132) (22,895)
Change in accrued income taxes     9,481 41,272
Change in liabilities     20,886 (14,043)
Net cash provided by operating activities     55,658 22,116
Cash flows from investing activities:        
Capital expenditures     (79,374) (38,430)
Cash Acquired from Acquisition       (292)
Proceeds from the sale of assets     1,008 2,834
Net Cash Provided by (Used in) Investing Activities     (78,366) (35,888)
Cash flows from financing activities:        
Proceeds from debt issuance     0 0
Repayments of long term debt     0  
Paydown on term note     0 0
Payment of debt issuance costs     0 0
Payments of debt extinguishment costs     0  
Excess tax benefit from stock-based compensation     0 0
Intercompany advances, net     21,836 7,792
Net cash used in financing activities     21,836 7,792
Net change in cash and cash equivalents     (872) (5,980)
Cash and cash equivalents, beginning of year     8,310 11,023
Cash and cash equivalents, end of period 7,438 5,043 7,438 5,043
Total operating gross margin 41,234 39,423 67,950 66,356
General and Administrative Expense 6,355 22,033 14,819 34,769
Total operating income 35,391 18,233 53,563 33,539
Interest Expense 35 35 85 58
Interest income 201 1,144 378 1,333
Total other expense 223 757 477 1,025
Income (benefit) before income taxes 35,614 18,990 54,040 34,564
Income tax expense 13,466 12,181 19,849 17,770
Less: Net income (loss) attributable to noncontrolling interest 0 0 0 0
Net income attributable to controlling interest 22,148 6,809 34,191 16,794
Non-Guarantor [Member]
        
Condensed Financial Statements [Line Items]        
Revenues 155,832 132,008 304,964 218,308
Operating expenses 138,409 107,426 271,224 189,101
Gain (Loss) on Derivative Instruments, Net, Pretax   0   0
Other 975 (107)   (411)
Cash flows from operating activities:        
Net income (1,333) 7,112 (2,729) (2,714)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization 15,172 13,732 29,342 24,412
Gain on disposition of assets 0 0 0 0
(Gain) loss on disposition of assets (507) 326 (538) 287
Deferred income tax benefit     2,346 99
Other Asset Impairment Charges       0
Expenses not requiring cash     1,806 1,208
Equity in net earnings of subsidiaries 0 0 0 0
Change in other assets     13,065 3,903
Change in accounts receivable     5,066 115,947
Change in accrued income taxes     (8,237) (3,796)
Change in liabilities     4,532 2,720
Net cash provided by operating activities     44,653 142,066
Cash flows from investing activities:        
Capital expenditures     (26,814) (25,107)
Cash Acquired from Acquisition       (117,699)
Proceeds from the sale of assets     2,338 67
Net Cash Provided by (Used in) Investing Activities     (24,476) (142,739)
Cash flows from financing activities:        
Proceeds from debt issuance     0 0
Repayments of long term debt     0  
Paydown on term note     0 0
Payment of debt issuance costs     0 0
Payments of debt extinguishment costs     0  
Excess tax benefit from stock-based compensation     0 0
Intercompany advances, net     (19,217) 15,920
Net cash used in financing activities     (19,217) 15,920
Net change in cash and cash equivalents     960 15,247
Cash and cash equivalents, beginning of year     51,682 34,612
Cash and cash equivalents, end of period 52,642 49,859 52,642 49,859
Total operating gross margin 2,251 10,850 4,398 4,795
General and Administrative Expense 418 124 848 190
Total operating income 2,340 10,400 4,088 4,318
Interest Expense 1,913 2,207 4,412 5,625
Interest income 2,439 2,842 5,080 5,558
Total other expense 1,501 528 2,411 (478)
Income (benefit) before income taxes 3,841 10,928 6,499 3,840
Income tax expense 5,174 3,816 9,228 6,554
Less: Net income (loss) attributable to noncontrolling interest 156 93 313 73
Net income attributable to controlling interest (1,489) 7,019 (3,042) (2,787)
Eliminations [Member]
        
Condensed Financial Statements [Line Items]        
Revenues (44,769) (27,855) (88,107) (51,362)
Operating expenses (44,769) (27,855) (88,107) (51,362)
Gain (Loss) on Derivative Instruments, Net, Pretax   0   0
Other 0 0 0 0
Cash flows from operating activities:        
Net income (20,659) (13,828) (31,149) (14,007)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:        
Depreciation and amortization 0 0 0 0
Gain on disposition of assets 0 0 0 0
(Gain) loss on disposition of assets 0 0 0 0
Deferred income tax benefit     0 0
Other Asset Impairment Charges       0
Expenses not requiring cash     0 0
Equity in net earnings of subsidiaries 20,659 13,828 31,149 14,007
Change in other assets     0 0
Change in accounts receivable     0 0
Change in accrued income taxes     0 0
Change in liabilities     0 0
Net cash provided by operating activities     0 0
Cash flows from investing activities:        
Capital expenditures     0 0
Cash Acquired from Acquisition       0
Proceeds from the sale of assets     0 0
Net Cash Provided by (Used in) Investing Activities     0 0
Cash flows from financing activities:        
Proceeds from debt issuance     0 0
Repayments of long term debt     0  
Paydown on term note     0 0
Payment of debt issuance costs     0 0
Payments of debt extinguishment costs     0  
Excess tax benefit from stock-based compensation     0 0
Intercompany advances, net     0 0
Net cash used in financing activities     0 0
Net change in cash and cash equivalents     0 0
Cash and cash equivalents, beginning of year     0 0
Cash and cash equivalents, end of period 0 0 0 0
Total operating gross margin 0 0 0 0
General and Administrative Expense 0 0 0 0
Total operating income 0 0 0 0
Interest Expense (2,648) (3,220) (5,873) (7,635)
Interest income (2,648) (3,220) (5,873) (7,635)
Total other expense (20,659) (13,828) (31,149) (14,007)
Income (benefit) before income taxes (20,659) (13,828) (31,149) (14,007)
Income tax expense 0 0 0 0
Less: Net income (loss) attributable to noncontrolling interest 0 0 0 0
Net income attributable to controlling interest $ (20,659) $ (13,828) $ (31,149) $ (14,007)